The study showed a 16.3-fold increase in antibodies for the mRNA RBD-TM vaccine compared with 1.3 for the ancestral vaccine, despite previous exposure to the SARS-CoV-2 virus, suggesting the ...

Researchers review decades of progress in human cytomegalovirus (HCMV) vaccine development, emphasizing challenges, ...

Beyond sidestepping people’s fear of needles, these vaccines would also make it easier to store and distribute ahead of ...

The report also includes an extensive assessment of the leading players' product portfolio and geographic presence and the key growth strategies adopted by them over the past three to four years. In ...

The largest COVID vaccine study to date has identified some risks associated with the shot. Researchers from the Global ...

The 25,000-subject study is testing a nucleoside-modified mRNA (modRNA), quadrivalent vaccine that is targeted against four strains of the flu virus that the World Health Organization (WHO ...

Convidecia is under clinical development by CanSino Biologics and currently in Phase III for Coronavirus Disease 2019 (COVID-19).

CS Analytical Laboratory, the world's only FDA regulated contract laboratory exclusively dedicated to providing regulatory ...

Moderna's mRNA vaccine platform has already delivered the widely used COVID-19 shot, and is being deployed against a host of other infectious diseases, including influenza, respiratory syncytial ...

According to the latest reports from Russia, the country has developed an innovative mRNA cancer vaccine. Russia has created a cancer vaccine using mRNA technology, which is different from ...